scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1017114460 |
P356 | DOI | 10.1186/1742-4690-10-111 |
P932 | PMC publication ID | 3827937 |
P698 | PubMed publication ID | 24156545 |
P5875 | ResearchGate publication ID | 258042255 |
P50 | author | Frank Kirchhoff | Q15451512 |
Christine Goffinet | Q79511859 | ||
Daniela Krnavek | Q125316562 | ||
Veronika Lodermeyer | Q125316600 | ||
P2093 | author name string | Tanja Waldmann | |
Jan Münch | |||
Christina M Stürzel | |||
Christian Dietz | |||
Christian Kolbe | |||
Kristina Suhr | |||
Nicola Schrott | |||
P2860 | cites work | Few and far between: how HIV may be evading antibody avidity | Q21090507 |
The secreted tumor-associated antigen 90K is a potent immune stimulator | Q24314376 | ||
Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain | Q24316043 | ||
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein | Q24635842 | ||
Cyclophilin C-associated protein: a normal secreted glycoprotein that down-modulates endotoxin and proinflammatory responses in vivo | Q24672890 | ||
The cyclophilins | Q24812580 | ||
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein | Q27860488 | ||
Functional studies on recombinant domains of Mac-2-binding protein | Q28203993 | ||
Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion | Q28290516 | ||
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu | Q29547836 | ||
The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein | Q29619540 | ||
SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. | Q30421200 | ||
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals | Q33535874 | ||
Dissecting interferon-induced transcriptional programs in human peripheral blood cells | Q33546362 | ||
Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells | Q33603453 | ||
CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection | Q33826740 | ||
Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells | Q34120302 | ||
Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins | Q34123672 | ||
Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins | Q34332728 | ||
The SRCR superfamily: a family reminiscent of the Ig superfamily | Q34338190 | ||
Effects of IFN alpha on late stages of HIV-1 replication cycle | Q34484926 | ||
Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas | Q35063118 | ||
Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected | Q35076987 | ||
HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation | Q35113720 | ||
HIV Restriction Factors and Mechanisms of Evasion | Q35902681 | ||
Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease. | Q35975990 | ||
Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120 | Q36687567 | ||
Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo | Q37256641 | ||
Monoclonal antibodies specific for human tumor-associated antigen 90K/Mac-2 binding protein: tools to examine protein conformation and function | Q38313181 | ||
Anti-HIV state but not apoptosis depends on IFN signature in CD4+ T cells | Q38883638 | ||
Human immunodeficiency virus type 1 envelope proteins traffic toward virion assembly sites via a TBC1D20/Rab1-regulated pathway. | Q39409784 | ||
Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection | Q39593653 | ||
Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue | Q39751463 | ||
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics | Q40211546 | ||
Isolation and functional characterization of the human 90K promoter | Q42817120 | ||
Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children | Q43738629 | ||
90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection. | Q45780008 | ||
Lipoprotein 90K in human immunodeficiency virus-infected patients: a further serologic marker of progression | Q45854416 | ||
Unusually high level of a tumor-associated antigen in the serum of human immunodeficiency virus-seropositive individuals | Q45854590 | ||
Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients | Q45873509 | ||
A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men. | Q53831094 | ||
Domain organization of Mac-2 binding protein and its oligomerization to linear and ring-like structures | Q56918500 | ||
Lack of mother-to-child HIV-1 transmission is associated with elevated serum levels of 90 K immune modulatory protein | Q63413191 | ||
Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections | Q63413197 | ||
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells | Q63413202 | ||
Recombinant human leukocyte interferon-alpha 2b stimulates the synthesis and release of a 90K tumor-associated antigen in human breast cancer cells | Q68467544 | ||
Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer | Q68871731 | ||
Identification of a novel serum protein secreted by lung carcinoma cells | Q68882683 | ||
90K (Mac-2 BP) in human milk | Q73215690 | ||
P921 | main subject | infectivity | Q1662346 |
P304 | page(s) | 111 | |
P577 | publication date | 2013-10-24 | |
P1433 | published in | Retrovirology | Q15793508 |
P1476 | title | 90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1 | |
P478 | volume | 10 |
Q91800366 | A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin |
Q59791100 | A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV |
Q36086989 | Antiviral gene expression in psoriasis |
Q38671133 | Cellular Antiviral Factors that Target Particle Infectivity of HIV-1 |
Q90616835 | Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor |
Q40640876 | Guanylate binding protein 5: Impairing virion infectivity by targeting retroviral envelope glycoproteins |
Q64972531 | HIV-1 Envelope Glycoprotein at the Interface of Host Restriction and Virus Evasion. |
Q30369227 | Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs |
Q47550785 | Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane |
Q47552023 | Interferons and beyond: Induction of antiretroviral restriction factors |
Q39748338 | KNIME for Open-Source Bioimage Analysis: A Tutorial |
Q37239856 | M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner |
Q47555946 | Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature |
Q39419975 | Role of Innate Genes in HIV Replication |
Q54216802 | The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K is Species-Specific. |
Q92734574 | Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression |
Search more.